$372 Million is the total value of DAFNA Capital Management LLC's 87 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 23.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | Sell | SPDR SP BIOTECH ETFetf | $44,895,000 | -1.4% | 566,000 | -7.7% | 12.08% | -2.7% |
| STXS | STEREOTAXIS INC | $24,625,000 | -2.2% | 13,680,554 | 0.0% | 6.62% | -3.5% | |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $17,213,000 | +30.4% | 261,235 | -0.0% | 4.63% | +28.7% |
| BHVN | BIOHAVEN PHARMACTL HLDG CO L | $16,644,000 | +3.7% | 110,100 | 0.0% | 4.48% | +2.4% | |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $14,014,000 | +8.3% | 135,712 | -2.5% | 3.77% | +6.9% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $13,546,000 | +1.5% | 375,223 | -14.5% | 3.64% | +0.2% |
| ACET | ADICET BIO INC | $13,307,000 | -2.6% | 935,766 | 0.0% | 3.58% | -3.9% | |
| FATE | Sell | FATE THERAPEUTICS INC | $12,100,000 | -11.4% | 539,940 | -2.0% | 3.25% | -12.6% |
| IBB | ISHARES TR NASDAQ BIOTECH INDXetf | $11,988,000 | -0.6% | 102,500 | 0.0% | 3.22% | -1.9% | |
| RVMD | Buy | REVOLUTION MEDICINES INC | $9,461,000 | +61.9% | 479,785 | +60.0% | 2.54% | +59.8% |
| CYTK | Sell | CYTOKINETICS INC | $8,915,000 | +7.3% | 183,995 | -13.0% | 2.40% | +5.9% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $8,542,000 | +19.7% | 355,487 | -4.2% | 2.30% | +18.1% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $8,513,000 | +5.7% | 80,155 | -3.0% | 2.29% | +4.3% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $8,035,000 | +6.1% | 538,561 | -1.8% | 2.16% | +4.8% |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $7,686,000 | +38.7% | 781,112 | +12.2% | 2.07% | +36.9% |
| NRIX | NURIX THERAPEUTICS INC | $7,384,000 | +2.8% | 566,695 | 0.0% | 1.99% | +1.5% | |
| ISEE | Sell | IVERIC BIO INC | $7,202,000 | +86.0% | 401,476 | -0.2% | 1.94% | +83.6% |
| SAGE | SAGE THERAPEUTICS INC | $7,061,000 | +21.2% | 180,306 | 0.0% | 1.90% | +19.7% | |
| KRTX | Sell | KARUNA THERAPEUTICS INC | $6,497,000 | -17.2% | 28,886 | -53.4% | 1.75% | -18.4% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $5,961,000 | +13.0% | 1,703,235 | -4.7% | 1.60% | +11.6% |
| DXCM | DEXCOM INC | $5,843,000 | +8.1% | 72,552 | 0.0% | 1.57% | +6.6% | |
| MRUS | Buy | MERUS N V | $5,546,000 | -6.8% | 276,893 | +5.3% | 1.49% | -8.0% |
| MORF | MORPHIC HLDG INC | $5,532,000 | +30.4% | 195,467 | 0.0% | 1.49% | +28.7% | |
| ALEC | Sell | ALECTOR INC | $5,037,000 | -10.3% | 532,438 | -3.6% | 1.36% | -11.4% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $5,001,000 | -6.4% | 71,600 | -10.1% | 1.34% | -7.7% |
| IPSC | CENTURY THERAPEUTICS INC | $4,701,000 | +17.7% | 475,367 | 0.0% | 1.26% | +16.2% | |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $4,675,000 | -1.7% | 178,717 | -4.8% | 1.26% | -3.1% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $4,648,000 | +114.4% | 307,232 | +6.3% | 1.25% | +111.5% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $4,504,000 | +2.8% | 65,946 | -32.0% | 1.21% | +1.3% |
| CSII | CARDIOVASCULAR SYS INC | $3,978,000 | -3.5% | 286,988 | 0.0% | 1.07% | -4.7% | |
| AXGN | AXOGEN INC | $3,959,000 | +45.6% | 332,103 | 0.0% | 1.06% | +43.7% | |
| ETNB | Sell | 89BIO INC | $3,792,000 | +53.6% | 654,862 | -14.6% | 1.02% | +51.6% |
| KALV | Sell | KALVISTA PHARMACEUTICALS INC | $3,705,000 | +41.7% | 255,313 | -3.9% | 1.00% | +39.9% |
| FSTX | F-STAR THERAPEUTICS INC | $2,954,000 | -18.2% | 576,881 | 0.0% | 0.80% | -19.2% | |
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $2,842,000 | +29.1% | 122,200 | -6.9% | 0.76% | +27.3% |
| KURA | Buy | KURA ONCOLOGY INC | $2,818,000 | +30.5% | 206,329 | +75.1% | 0.76% | +28.7% |
| ATRC | ATRICURE INC | $2,816,000 | -4.3% | 72,029 | 0.0% | 0.76% | -5.6% | |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $2,554,000 | +35.9% | 377,763 | -7.1% | 0.69% | +34.2% |
| MDWD | New | MEDIWOUND LTD | $1,986,000 | – | 1,428,571 | +100.0% | 0.53% | – |
| Buy | VIGIL NEUROSCIENCE INC | $1,969,000 | +666.1% | 216,395 | +116.9% | 0.53% | +657.1% | |
| ARAY | ACCURAY INC | $1,959,000 | +6.1% | 941,800 | 0.0% | 0.53% | +4.8% | |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $1,859,000 | -14.3% | 97,560 | -7.3% | 0.50% | -15.4% |
| LRMR | Buy | LARIMAR THERAPEUTICS INC | $1,840,000 | +1777.6% | 574,996 | +1050.1% | 0.50% | +1733.3% |
| GLPG | GALAPAGOS NVspon adr | $1,820,000 | -23.6% | 42,675 | 0.0% | 0.49% | -24.5% | |
| New | SYROS PHARMACEUTICALS INC | $1,712,000 | – | 265,878 | +100.0% | 0.46% | – | |
| Sell | DICE THERAPEUTICS INC | $1,592,000 | -34.6% | 78,500 | -50.0% | 0.43% | -35.5% | |
| VKTX | Buy | VIKING THERAPEUTICS INC | $1,503,000 | +12.5% | 552,400 | +19.5% | 0.40% | +11.0% |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,476,000 | +14.2% | 1,500,000 | 0.0% | 0.40% | +12.8% | ||
| KROS | KEROS THERAPEUTICS INC | $1,467,000 | +36.1% | 39,000 | 0.0% | 0.40% | +34.4% | |
| AFMD | AFFIMED N V | $1,414,000 | -25.6% | 686,282 | 0.0% | 0.38% | -26.6% | |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $1,323,000 | -29.0% | 413,526 | -0.6% | 0.36% | -29.9% |
| SURF | SURFACE ONCOLOGY INC | $1,144,000 | -36.6% | 1,100,000 | 0.0% | 0.31% | -37.4% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $1,062,000 | -24.4% | 496,150 | 0.0% | 0.29% | -25.3% | |
| STIM | NEURONETICS INC | $998,000 | -0.9% | 313,717 | 0.0% | 0.27% | -2.2% | |
| NGM | Sell | NGM BIOPHARMACEUTICALS INC | $980,000 | -29.0% | 74,953 | -30.4% | 0.26% | -29.8% |
| GMDA | New | GAMIDA CELL LTD | $978,000 | – | 614,896 | +100.0% | 0.26% | – |
| New | BIOHAVEN LTD | $967,000 | – | 153,564 | +100.0% | 0.26% | – | |
| SCYX | Sell | SCYNEXIS INC | $958,000 | +13.4% | 399,064 | -12.2% | 0.26% | +12.2% |
| REGULUS THERAPEUTICS INC | $944,000 | -17.9% | 555,555 | 0.0% | 0.25% | -18.8% | ||
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $944,000 | -23.1% | 1,096,513 | 0.0% | 0.25% | -24.2% | |
| KNTE | Sell | KINNATE BIOPHARMA INC | $933,000 | -67.0% | 78,074 | -65.2% | 0.25% | -67.4% |
| Buy | PARDES BIOSCIENCES INC | $887,000 | -36.0% | 479,386 | +6.3% | 0.24% | -36.6% | |
| BWAY | Buy | BRAINSWAY LTDsponsored ads | $794,000 | -17.8% | 220,000 | +10.0% | 0.21% | -18.6% |
| GNFT | GENFIT S Aads | $686,000 | +13.4% | 187,940 | 0.0% | 0.18% | +12.1% | |
| MEIP | MEI PHARMA INC | $683,000 | -36.1% | 1,767,146 | 0.0% | 0.18% | -36.8% | |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $612,000 | +11.5% | 52,631 | -4.3% | 0.16% | +10.0% |
| MDNA | New | MEDICENNA THERAPEUTICS CORP | $548,000 | – | 660,000 | +100.0% | 0.15% | – |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $530,000 | -31.3% | 313,600 | 0.0% | 0.14% | -31.9% | |
| NXTC | NEXTCURE INC | $516,000 | -41.5% | 187,696 | 0.0% | 0.14% | -42.1% | |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $508,000 | -37.3% | 47,390 | -36.7% | 0.14% | -38.0% |
| PRQR | New | PROQR THERAPEUTICS NV | $483,000 | – | 649,383 | +100.0% | 0.13% | – |
| THESEUS PHARMACEUTICALS INC | $475,000 | +4.9% | 81,899 | 0.0% | 0.13% | +4.1% | ||
| STRO | Sell | SUTRO BIOPHARMA INC | $451,000 | +2.3% | 81,200 | -4.1% | 0.12% | +0.8% |
| OTIC | OTONOMY INC | $434,000 | -85.8% | 1,470,199 | 0.0% | 0.12% | -86.0% | |
| IKNA | New | IKENA ONCOLOGY INC | $435,000 | – | 122,517 | +100.0% | 0.12% | – |
| VERO | VENUS CONCEPT INC | $426,000 | -5.1% | 968,187 | 0.0% | 0.12% | -5.7% | |
| CMPX | Sell | COMPASS THERAPEUTICS INC | $429,000 | -18.3% | 188,094 | -5.0% | 0.12% | -19.6% |
| MASI | MASIMO CORP | $423,000 | +7.9% | 3,000 | 0.0% | 0.11% | +6.5% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $377,000 | -36.9% | 351,064 | 0.0% | 0.10% | -38.0% | |
| INGN | INOGEN INC | $364,000 | +0.3% | 15,000 | 0.0% | 0.10% | -1.0% | |
| MGNX | Sell | MACROGENICS INC | $346,000 | -38.9% | 100,000 | -47.9% | 0.09% | -39.6% |
| BMEA | Sell | BIOMEA FUSION INC | $339,000 | -79.3% | 34,625 | -74.7% | 0.09% | -79.6% |
| SPRO | New | SPERO THERAPEUTICS INC | $250,000 | – | 125,000 | +100.0% | 0.07% | – |
| LCTX | LINEAGE CELL THERAPEUTICS IN | $158,000 | -28.5% | 140,000 | 0.0% | 0.04% | -30.0% | |
| New | REUNION NEUROSCIENCE INC | $138,000 | – | 96,585 | +100.0% | 0.04% | – | |
| CGEN | COMPUGEN LTDord | $135,000 | -64.5% | 205,202 | 0.0% | 0.04% | -65.4% | |
| PHAS | Sell | PHASEBIO PHARMACEUTICALS INC | $57,000 | -74.9% | 321,856 | -15.0% | 0.02% | -75.8% |
| ANNX | Exit | ANNEXON INC | $0 | – | -40,796 | -100.0% | -0.04% | – |
| ASLN | Exit | ASLAN PHARMACEUTICALS LTDads | $0 | – | -343,720 | -100.0% | -0.05% | – |
| CNTB | Exit | CONNECT BIOPHARMA HLDGS LTDads | $0 | – | -250,000 | -100.0% | -0.06% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -3,100 | -100.0% | -0.06% | – |
| LVTX | Exit | LAVA THERAPEUTICS NV | $0 | – | -128,335 | -100.0% | -0.10% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -390,066 | -100.0% | -0.12% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -91,935 | -100.0% | -0.26% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -372,361 | -100.0% | -0.33% | – |
| Exit | FIELD TRIP HEALTH LTD | $0 | – | -1,904,141 | -100.0% | -0.44% | – | |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -48,452 | -100.0% | -0.99% | – |
| Exit | RADIUS HEALTH INCnote 3.000% 9/0 | $0 | – | -4,000,000 | -100.0% | -1.07% | – | |
| NTUS | Exit | NATUS MEDICAL INC | $0 | – | -143,600 | -100.0% | -1.28% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.